Adaptive Phage Therapeutics logo

Adaptive Phage Therapeutics


Adaptive Phage Therapeutics (APT) is a clinical-stage company advancing therapies addressing multi-drug resistant infections. Prior antimicrobial therapeutic approaches have been “fixed,” while pathogens continue to evolve resistance to each of those therapeutics, causing those drug products to become rapidly less effective in commercial use as antimicrobial resistance (AMR) increases over time.


Add photos to showcase Adaptive Phage Therapeutics’s culture


Add Adaptive Phage Therapeutics’s values

Insider experiences

Share your experience of working at Adaptive Phage Therapeutics

Subhendu Basu
President & COO
Robert J. Hopkins
Chief Medical Officer
Carl R. Merril
Chief Scientific Officer
Michael King
Chief Business Officer
Michele Wales
Chief Legal Officer
Michael Orndorff
VP, Finance & Administration

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure